Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22375971

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2012 Mar 1
First author
Verstovsek S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2012 Mar 1;366(9):844-6. doi: 10.1056/NEJMe1115119.
    note
    Source null
    related pmid
    22375977
    relationship
    Comment in
  2. citation
    N Engl J Med. 2012 May 24;366(21):2032; author reply 2032-5. doi: 10.1056/NEJMc1203704.
    note
    Source null
    related pmid
    22621635
    relationship
    Comment in

Authors and identifiers

  1. name
    Verstovsek S
    type
    Author
  2. name
    Mesa RA
    type
    Author
  3. name
    Gotlib J
    type
    Author
  4. name
    Levy RS
    type
    Author
  5. name
    Gupta V
    type
    Author
  6. name
    DiPersio JF
    type
    Author
  7. name
    Catalano JV
    type
    Author
  8. name
    Deininger M
    type
    Author
  9. name
    Miller C
    type
    Author
  10. name
    Silver RT
    type
    Author
  11. name
    Talpaz M
    type
    Author
  12. name
    Winton EF
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Verstovsek S
    type
    Author
  2. name
    Mesa RA
    type
    Author
  3. name
    Gotlib J
    type
    Author
  4. name
    Levy RS
    type
    Author
  5. name
    Gupta V
    type
    Author
  6. name
    DiPersio JF
    type
    Author
  7. name
    Catalano JV
    type
    Author
  8. name
    Deininger M
    type
    Author
  9. name
    Miller C
    type
    Author
  10. name
    Silver RT
    type
    Author
  11. name
    Talpaz M
    type
    Author
  12. name
    Winton EF
    type
    Author
bibliography ids
  1. nci-bib-a316163d08a8c46caca32b76
book metadata
content sha256
c77bc88019393af82a166be2a9142becbaa5df5160cdd442fa3327cba2464425
document type
citation
dois
  1. 10.1056/NEJMoa1110557
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:22375971
immutable id
pubmed:22375971@c77bc88019393af82a166be2a9142becbaa5df5160cdd442fa3327cba2464425
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
9
name
The New England journal of medicine
nlm unique id
0255562
pages
799-807
volume
366
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2012 Mar 1;366(9):844-6. doi: 10.1056/NEJMe1115119.
    note
    Source null
    related pmid
    22375977
    relationship
    Comment in
  2. citation
    N Engl J Med. 2012 May 24;366(21):2032; author reply 2032-5. doi: 10.1056/NEJMc1203704.
    note
    Source null
    related pmid
    22621635
    relationship
    Comment in
outcomes validated
false
pmid
22375971
provenance
batch id
b6284687e167e7da9556
provider
NCBI PubMed ESummary
record sha256
a1494e6350ebdff30b9064b27486bdecfd7629457275ef2620e224d906aecfe9
response sha256
64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
retrieved at
2026-09-09T23:46:45.216259+00:00
publication date
display
2012 Mar 1
precision
day
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22375971/
title
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.

Preserved source evidence · Not medical advice